As endothelial cells die after ischaemic injury, they induce the destruction of nearby red blood cells through haemolysis, a process that is similar to a balloon popping. The membranes of these ...

The study, published in Nature, opens new avenues for treating some genetic blood disorders without the need for stem cell transplantation or chemotherapy. SR-Tiget is internationally recognized ...

Homology-directed repair (HDR)-based gene editing in hematopoietic stem and progenitor cells (HSPCs) holds great promise for the treatment of genetic blood diseases. Despite significant advances ...

It affects the outer edge — also known as the mantle zone — of a type of white blood cell called B-cells or B lymphocytes, the Leukaemia Foundation says. What this means is that the body is ...

The study, published in Cell Reports Medicine, outlines new strategies to overcome this hurdle, improving both the safety and efficacy of gene-editing-based therapies for inherited blood disorders.

A low red blood cell (RBC) count increases the risk of anemia. Ways to boost RBCs include eating foods that contain iron, vitamins B12 and B9, vitamin C, vitamin A, and copper. Increasing exercise ...

Dr. Al-Awadhi emphasized the Ministry’s commitment to improving patient care, including introducing treatments to manage iron overload from frequent transfusions and supporting alternatives that ...

(CNN) — Here is some background ... cells, but are more limited compared with embryonic stem cells. They are more likely to generate within a particular tissue, organ or physiological system ...

Macy Meyer is a North Carolina native who graduated from UNC-Chapel Hill with a BA in English and a second BA in Journalism. Macy is a Writer on the CNET How-To team, covering a variety of topics ...

Normochromic Describes RBCs that are normal in color, containing the normal amount ofhemoglobin Normochromic cells are seen in anemia following acute blood loss Normocyte Normal sized ...

The study, published in Cell Reports Medicine, outlines new strategies to overcome this hurdle, improving both the safety and efficacy of gene-editing-based therapies for inherited blood disorders.